ATE493118T1 - Biologisch wirksame zusammensetzung mit ethylcellulose - Google Patents

Biologisch wirksame zusammensetzung mit ethylcellulose

Info

Publication number
ATE493118T1
ATE493118T1 AT06844392T AT06844392T ATE493118T1 AT E493118 T1 ATE493118 T1 AT E493118T1 AT 06844392 T AT06844392 T AT 06844392T AT 06844392 T AT06844392 T AT 06844392T AT E493118 T1 ATE493118 T1 AT E493118T1
Authority
AT
Austria
Prior art keywords
ethylcellulose
biologically effective
effective composition
composition
biologically active
Prior art date
Application number
AT06844392T
Other languages
English (en)
Inventor
Mark J Hall
Karen A Coppens
Pamela S Larsen
Shawn A Mitchell
Michael D Read
Uma Shrestha
Original Assignee
Dow Global Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies Inc filed Critical Dow Global Technologies Inc
Application granted granted Critical
Publication of ATE493118T1 publication Critical patent/ATE493118T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT06844392T 2006-01-19 2006-11-17 Biologisch wirksame zusammensetzung mit ethylcellulose ATE493118T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76025306P 2006-01-19 2006-01-19
US78893806P 2006-04-04 2006-04-04
PCT/US2006/044557 WO2007084212A2 (en) 2006-01-19 2006-11-17 Biologically active composition comprising ethylcellulose

Publications (1)

Publication Number Publication Date
ATE493118T1 true ATE493118T1 (de) 2011-01-15

Family

ID=37898565

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06844392T ATE493118T1 (de) 2006-01-19 2006-11-17 Biologisch wirksame zusammensetzung mit ethylcellulose

Country Status (9)

Country Link
US (1) US9198865B2 (de)
EP (1) EP1978940B1 (de)
JP (1) JP5249050B2 (de)
CN (1) CN101360483B (de)
AT (1) ATE493118T1 (de)
CA (1) CA2636339C (de)
DE (1) DE602006019320D1 (de)
IL (1) IL192611A (de)
WO (1) WO2007084212A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010007645A (es) * 2008-01-11 2010-11-05 Cipla Ltd Forma de dosis farmaceutica solida.
CN102892815B (zh) * 2010-03-26 2016-05-18 陶氏环球技术有限责任公司 熔体挤出的膜
EP2555912A2 (de) * 2010-03-26 2013-02-13 Dow Global Technologies LLC Verfahren zur herstellung einer schmelzextrudierten folie und schmelzextrudierte folie
JP2014525423A (ja) 2011-08-30 2014-09-29 ウニベルシテイト ヘント 多層放出配合物
US11697242B2 (en) * 2015-07-27 2023-07-11 Nutrition & Biosciences Usa 1, Llc Method to additive manufacture biocompatible material and articles made by the method
EP3459527B1 (de) 2017-09-20 2022-11-23 Tillotts Pharma Ag Verfahren zur herstellung einer festen dosierungsform mit antikörpern durch nassgranulation, -extrusion und -sphäronisierung
JP2020536059A (ja) * 2017-10-02 2020-12-10 ノバルティス アーゲー 医薬担体を製造するための方法
US20220062305A1 (en) 2018-12-18 2022-03-03 DDP Specialty Electronic Materials US, Inc. Sustained release composition comprising an ethylcellulose
WO2020131800A1 (en) 2018-12-18 2020-06-25 DDP Specialty Electronic Materials US, Inc. A sustained release composition comprising an ethylcellulose

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2257104A (en) 1939-11-09 1941-09-30 Du Pont Extrusion method for organic materials
US3941865A (en) 1973-12-10 1976-03-02 Union Carbide Corporation Extrusion of ethylene oxide resins
US4645812A (en) 1983-02-28 1987-02-24 Henkel Corporation Method of suspension polymerization of vinyl chloride
US4678516A (en) 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
USRE33093E (en) * 1986-06-16 1989-10-17 Johnson & Johnson Consumer Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
TW207987B (de) 1991-03-20 1993-06-21 Hoechst Ag
ES2325046T3 (es) 1996-06-26 2009-08-24 The Board Of Regents, The University Of Texas System Formulacion farmaceutica extruible por fusion en caliente.
US5966582A (en) 1996-10-28 1999-10-12 Corning Incorporated Method for rapid stiffening of extrudates
GT199900148A (es) * 1998-09-10 2001-02-28 Desnaturalizantes para las sales aminas simpaticomimeticas.
US6375963B1 (en) * 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
WO2001062229A1 (en) 2000-02-24 2001-08-30 Advanced Pharma, Inc. Therapeutic product, use and formulation thereof
WO2002035991A2 (en) 2000-10-30 2002-05-10 The Board Of Regents, The University Of Texas System Spherical particles produced by a hot-melt extrusion/spheronization process
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US7666337B2 (en) 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
ATE399538T1 (de) * 2003-03-26 2008-07-15 Egalet As Matrixzubereitungen für die kontrollierte darreichung von arzneistoffen

Also Published As

Publication number Publication date
CA2636339A1 (en) 2007-07-26
EP1978940A2 (de) 2008-10-15
US9198865B2 (en) 2015-12-01
US20090130058A1 (en) 2009-05-21
JP2009523793A (ja) 2009-06-25
CN101360483A (zh) 2009-02-04
EP1978940B1 (de) 2010-12-29
IL192611A0 (en) 2009-02-11
CA2636339C (en) 2014-07-08
DE602006019320D1 (de) 2011-02-10
CN101360483B (zh) 2012-10-31
IL192611A (en) 2012-12-31
JP5249050B2 (ja) 2013-07-31
WO2007084212A3 (en) 2007-12-06
WO2007084212A2 (en) 2007-07-26

Similar Documents

Publication Publication Date Title
ATE493118T1 (de) Biologisch wirksame zusammensetzung mit ethylcellulose
DE602007012692D1 (de) Pharmazeutische zusammensetzung mit hydrochlorothiazid und telmisartan
DK1603565T3 (da) Medikament omfattende en höjaktiv længevarende beta2-agonisk i kombination med andre aktive ingredienser
CO6420388A2 (es) Formulacion que comprende particulas de avermectina cubiertas con un agente fotoprotector
PL1933809T3 (pl) Kompozycje do dostarczania donosowego
DOP2009000135A (es) Derivados de 2,3-dihidroimidazo [1,2-c] quinazolina sustituídos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogénesis
HRP20151202T1 (hr) Oralna formulacija metadoksina
ATE471144T1 (de) Intranasale verabreichung von schnell wirkendem insulin
IS6344A (is) Lyfjasamsetningar sem leiða til aukinna lyfjastyrkja
ITMI20062286A1 (it) Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi
WO2007012022A3 (en) Unit dose form with ibuprofen-famotidine admixture
IT1362675B (it) N-idrossiammidi -sostituiti con gruppi triciclici come inibitori dell'istone deacelitasi,loro preparazione ed impiego in formulazioni farmaceutiche
DE602006020070D1 (de) Verringerung von schwindel, einer nebenwirkung im zusammenhang mit einer pirfenidon-therapie
HRP20191489T1 (hr) Kombinirani sastav
AR059097A1 (es) Tratamiento a largo plazo de la infeccion por vih
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
DE602006016127D1 (de) Zusammensetzung und dosierform mit einer festen oder halbfesten matrix
ATE319729T1 (de) 9a-azalide mit entzündungshemmender wirkung
EA200870155A1 (ru) Система доставки лекарственного средства
DE602007011316D1 (de) Pharmazeutische zusammensetzung mit antipsychotischer, antidepressiver oder antiepileptischer wirkung mit verringerter nebenwirkung
DE602006010601D1 (de) Salze von clopidogrel mit polyanionen und ihre verwendung zur herstellung pharmazeutischer formulierungen
BRPI0405662A (pt) Emplastros contendo turobuterol
RU2006113043A (ru) Регулятор роста и развития сельскохозяйственных культур
BRPI0516957A (pt) formulação farmacêutica estabilizada de agente de leucotrieno b4 (ltb4)
NO20064123L (no) Farmasoytisk blanding av [+]-erytro-meflokin og dens anvendelse

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties